Metabolic Tumour Burden Measured by (18)F-FDG PET/CT Predicts Malignant Transformation in Patients with Neurofibromatosis Type-1

BACKGROUND: To investigate the diagnostic and prognostic performances of (18)F-FDG PET/CT measures of metabolic tumour burden in patients with neurofibromatosis type-1 (NF1), suspect of malignant transformation. METHODS: This retrospective study included 49 patients (15–60 years old, 30 women) with...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:PLoS One
Päätekijät: Van Der Gucht, Axel, Zehou, Ouidad, Djelbani-Ahmed, Soraya, Valeyrie-Allanore, Laurence, Ortonne, Nicolas, Brugières, Pierre, Wolkenstein, Pierre, Luciani, Alain, Rahmouni, Alain, Sbidian, Emilie, Itti, Emmanuel
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Public Library of Science 2016
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4795780/
https://ncbi.nlm.nih.gov/pubmed/26987124
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0151809
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia